Navigation Links
Doubled calorie intake from beverages likely contributes to adult obesity
Date:11/19/2007

Its not just sugary sodas that are adding to the obesity crisis its fruit drinks, alcohol and a combination of other high-calorie beverages, say University of North Carolina at Chapel Hill School of Public Health researchers. And during the holidays, when eggnog, cocktails and spiced cider are abundant, the problem can be even more apparent.

Over the past 37 years, the number of calories adults get through beverages has nearly doubled, according to a UNC study published in the November issue of Obesity Research by Kiyah J. Duffey, a doctoral candidate in the department of nutrition, and Barry M. Popkin, Ph.D., professor of nutrition and a fellow at the Carolina Population Center.

The study used nationally representative data to quantify both trends and patterns in beverage consumption among 46,576 American adults aged 19 and older. Patterns and trends of all beverages adults consumed were examined between 1965 and 2002. Researchers found that, over these 37 years, total daily intake of calories from beverages increased by 94 percent, providing an average 21 percent of daily energy intake among U.S. adults. That amounts to an additional 222 calories from all beverages daily.

Water intake was measured from 1989 to 2002, and during that time, the amount of water consumed stayed roughly the same, but the average adult consumed an additional 21 ounces per day of other beverages, Popkin said.

This has considerable implications for numerous health outcomes, including obesity and diabetes as this is just adding several hundred calories daily to our overall caloric intake, Popkin said.

Most researchers agree that beverages do not fill you up, Popkin said. Regardless of beverage type water, sodas, milk, orange juice or beer those extra calories are not compensated for by a reduction in food intake.

Data analyzed for this study came from the federally funded Nationwide Food Consumption Surveys of 1965 and 1977-1978
'/>"/>

Contact: Clinton Colmenares
clinton_colmenares@unc.edu
919-843-1991
University of North Carolina at Chapel Hill
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New Report: Dangerous Drug Side Effects and Deaths Doubled Since 1998... Seniors Hit Hardest
2. New Herbal Water Creating Taste Sensation: Ayalas Herbal Water Has No Calories, No Preservatives and No Artificial Additives. Just All the Natural Benefits of Herbs!
3. Lose Weight, Conquer World Hunger with www.DonateYourCalories.com
4. Calorie-Starved Rats Live Longer: Study
5. Empty-Calorie Diet Tied to Preclinical Heart Disease
6. Pressure to Promote Healthier Eating to Cause Minor Growing Pains for Kids Licensed Foods and Beverages
7. Major ORAC Differences Among Top Antioxidant Beverages
8. Minorities more likely to have sleep durations associated with increased mortality
9. Scientists ID Likely Culprit in Popcorn Lung
10. Pop stars more than twice as likely to die an early death
11. Smokers More Likely to Develop Dementia
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine Technology:Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases 2Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 2Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 3Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 4Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 5Cell Therapeutics Announces that the European Organization for Research and Treatment of Cancer Completes Enrollment in Phase II Clinical Trial of Brostallicin as First Line Therapy for Advanced or Metastatic Soft Tissue Sarcoma 6